CD44 is a transmembrane glycoprotein that acts as an endocytic HA receptor in human breast tumor cells [39]; therefore, future investigations should explore the interactions between ITIH2, hyaluronic acid, and CD44 in canine and human breast tumors, given the evidence of potential functional relationships. This evidence concerns the gene CD44 and breast neoplasm.